Your browser doesn't support javascript.
loading
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Holstein, Sarah A; Ye, J Christine; Howard, Alan; Bhutani, Manisha; Gormley, Nicole; Hahn, Theresa; Hillengass, Jens; Krishnan, Amrita; Landgren, C Ola; Munshi, Nikhil C; Oliva, Stefania; Owen, Roger G; Pasquini, Marcelo C; Puig, Noemi; Weinhold, Niels; Weisel, Katja; McCarthy, Philip L.
Afiliación
  • Holstein SA; Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: sarah.holstein@unmc.edu.
  • Ye JC; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan.
  • Howard A; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.
  • Bhutani M; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, North Carolina.
  • Gormley N; US Food and Drug Administration, Silver Spring, Maryland.
  • Hahn T; The Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Hillengass J; The Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Krishnan A; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Landgren CO; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Munshi NC; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Oliva S; Division of Hematology, Myeloma Unit, University of Torino, Torino, Italy.
  • Owen RG; Haematological Malignancy Diagnostic Service, St James's Institute of Oncology, Leeds, United Kingdom.
  • Pasquini MC; Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Puig N; Department of Hematology, Universit Hospital of Salamanca, Salamanca, Spain.
  • Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Weisel K; Department of Hematology, Oncology, Immunology and Rheumatology, Universitatsklinikum Tubingen, Tubingen, Germany.
  • McCarthy PL; The Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Biol Blood Marrow Transplant ; 25(3): e89-e97, 2019 03.
Article en En | MEDLINE | ID: mdl-30408566
ABSTRACT
The second annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 7, 2017, at the American Society of Hematology (ASH) meeting. During this workshop, investigators from around the world presented their latest research involving assessment of minimal residual disease (MRD) and immune profiling (IP) in myeloma. This document summarizes the workshop presentations as well as relevant ASH abstracts and focuses on the regulatory issues involved in the integration of MRD and IP assessment in clinical trial design and practice.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Neoplasia Residual / Congresos como Asunto / Educación / Factores Inmunológicos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Neoplasia Residual / Congresos como Asunto / Educación / Factores Inmunológicos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article